Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation

Srinivas Kantham, Stephen Chan, Gawain McColl, Jared A. Miles, Suresh Kumar Veliyath, Girdhar Singh Deora, Satish N. Dighe, Samira Khabbazi, Marie Odile Parat, Benjamin P. Ross

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

The biphenyl neolignan honokiol is a neuroprotectant which has been proposed as a treatment for central nervous system disorders such as Alzheimer's disease (AD). The death of cholinergic neurons in AD is attributed to multiple factors, including accumulation and fibrillation of amyloid beta peptide (Aβ) within the brain; metal ion toxicity; and oxidative stress. In this study, we used a transgenic Caenorhabditis elegans model expressing full length Aβ42 as a convenient in vivo system for examining the effect of honokiol against Aβ-induced toxicity. Furthermore, honokiol was evaluated for its ability to inhibit Aβ42 oligomerization and fibrillation; inhibit acetylcholinesterase and butyrylcholinesterase; scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals; and chelate iron(II). Honokiol displayed activity similar to that of resveratrol and (-)-epigallocatechin gallate (EGCG) in delaying Aβ42-induced paralysis in C. elegans, and it exhibited moderate-to-weak ability to inhibit Aβ42 on-pathway aggregation, inhibit cholinesterases, scavenge DPPH radicals, and chelate iron(II). Moreover, honokiol was found to be chemically stable relative to EGCG, which was highly unstable. Together with its good drug-likeness and brain availability, these results suggest that honokiol may be amenable to drug development and that the synthesis of honokiol analogues to optimize these properties should be considered.

Original languageEnglish
Pages (from-to)1901-1912
Number of pages12
JournalACS Chemical Neuroscience
Volume8
Issue number9
DOIs
Publication statusPublished - 20 Sep 2017
Externally publishedYes

Keywords

  • Alzheimer's disease
  • amyloid beta peptide
  • Caenorhabditis elegans
  • cholinesterases
  • honokiol

Cite this